clofibrate has been researched along with 2,4-thiazolidinedione in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, T; Ikeda, H; Kawamatsu, Y; Meguro, K; Sohda, T | 1 |
Chen, ZJ; Yang, LY; Yang, YN | 1 |
1 review(s) available for clofibrate and 2,4-thiazolidinedione
Article | Year |
---|---|
[Discovery and development of a new insulin sensitizing agent, pioglitazone].
Topics: Animals; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Design; Humans; Hypoglycemic Agents; Insulin Resistance; Mice; Pioglitazone; Thiazoles; Thiazolidinediones | 2002 |
1 other study(ies) available for clofibrate and 2,4-thiazolidinedione
Article | Year |
---|---|
[The effect of peroxisome proliferator-activated receptor alpha and gamma ligands on free fatty acid-induced INS-1 cell impairment].
Topics: Animals; Anticholesteremic Agents; Apoptosis; Cell Line, Tumor; Chromans; Clofibrate; Fatty Acids, Nonesterified; Hypoglycemic Agents; Insulinoma; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Troglitazone | 2003 |